From airway biopsies of COPD patients, expression of TGF-β1 and its downstream signaling partners Smad2/3 were greatly increased in COPD patients compared to normal, with the most prominent expression around blood vessels [38]. The gene discussed is SMAD2; the disease is chronic obstructive pulmonary disease.